EUCTR2017-000641-44-SE进行中（未招募）1 期
TailorDose®-II: Therapeutic dose monitoring of commonly used cytostatic drugs/regimes indicated for breast cancer - TailorDose-II
Karolinska intitutet0 个研究点目标入组 280 人开始时间: 2017年2月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1. Female patients aged = 18 years.
- •2. Treated with any, or a combination, of the drugs cyclophosphamide, epirubicin, doxorubicin, docetaxel and paclitaxel.
- •3. Written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 175
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 75
排除标准
- •1. Patients fulfilling any of the contraindications mentioned for the studied drugs.
- •2. Patients treated with a combinatorial regime of docetaxel, carboplatin and trastuzumab.
- •3. A decision of exclusion is taken by the treating oncologist at the respective oncological clinic.
研究者
相似试验
已完成
不适用
therapeutic drug monitoring: towards tailored dosing of adalimumab in rheumatoid arthritisrheumatoide arthritis10003816NL-OMON41716Reade, centrum voor Revalidatie en Reumatologie55
已完成
3 期
Therapeutic drug monitoring-based dose optimisation of piperacillin in patients with severe sepsis or septic shock to investigate effects on organ functions and survival: a prospective, multicenter, randomized controlled trialR65.1R57.2Systemic Inflammatory Response Syndrome of infectious origin with organ failureSeptic shockDRKS00011159Friedrich-Schiller-Universität Jena254
进行中（未招募）
1 期
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.MedDRA version: 20.0 Level: LLT Classification code 10060614 Term: Hemophilia B (Factor IX) System Organ Class: 100000004850MedDRA version: 20.0 Level: LLT Classification code 10060613 Term: Hemophilia A (Factor VIII) System Organ Class: 100000004850HemophiliaEUCTR2018-003869-33-NLErasmus University Medical Center50
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patientsNL-OMON27791Erasmus Medical Center, Sophia Children's Hospital50
尚未招募
不适用
Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients.hemophiliaNL-OMON55874Erasmus MC, Universitair Medisch Centrum Rotterdam50